Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications.
about
Revealing facts behind spray dried solid dispersion technology used for solubility enhancementSurface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and UsesNovel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptakeIntraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects metabolic reprogramming and effectively inhibits cancer stem cells in Taxol(®)-resistant ovarian cancerAssembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.Insights on novel particulate self-assembled drug delivery beads based on partial inclusion complexes between triglycerides and cyclodextrins.A perspective overview on lipospheres as lipid carrier systems.First in man bioavailability and tolerability studies of a silica-lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen.Solvent-free melting techniques for the preparation of lipid-based solid oral formulations.Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.Liposomes coated with thiolated chitosan enhance oral peptide delivery to ratsLipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.Evaluation of in vivo behavior of controlled and pulsatile release pastilles using pharmacokinetic and γ-scintigraphic techniques.Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions.
P2860
Q26748640-7A875CC4-E203-4482-AF44-C42BD2637C23Q28071773-57EE1E83-17EA-48AD-90C0-06B4769B03BEQ34098017-93682092-F3AC-4BBD-8EDB-56590966B442Q35826455-D5EFD95D-D2F4-41DC-8BD6-0698AEE7AFF9Q37967163-F8BA7BEF-E044-4BA2-9983-5DF9325E6485Q38115195-F32B3EC1-BCDA-4951-B956-37BE41309D7CQ38246043-76CEAA70-0E1C-4430-B153-A7E8811B4E1DQ38271617-A907052D-4E3F-4A12-9726-6F158B27B864Q38383057-D3C2F280-E87D-4CEF-B107-45B578A44805Q38383531-7938EDD7-57CF-48E1-99DC-ABBE90AC1155Q38729314-497C1610-88B1-4C3F-A634-783361500008Q39518383-D7203E37-CE2E-4AB7-9CE3-42D3EFC7C926Q41913979-0B0010C1-55C3-4367-BEA4-ABDA5486F13EQ42291896-AB7ADBC0-87A7-4505-B151-C9A0AD3681E7Q47218974-A1932CC9-09E4-44C4-96DC-16B87F3D9D1FQ50799182-F9AB5738-13A2-40EE-ABD7-2AADFE866419
P2860
Lipid-based oral multiparticulate formulations - advantages, technological advances and industrial applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipid-based oral multiparticul ...... s and industrial applications.
@en
Lipid-based oral multiparticul ...... s and industrial applications.
@nl
type
label
Lipid-based oral multiparticul ...... s and industrial applications.
@en
Lipid-based oral multiparticul ...... s and industrial applications.
@nl
prefLabel
Lipid-based oral multiparticul ...... s and industrial applications.
@en
Lipid-based oral multiparticul ...... s and industrial applications.
@nl
P2860
P1476
Lipid-based oral multiparticul ...... es and industrial applications
@en
P2093
Sanjay Singh
Subhashis Chakraborty
P2860
P304
P356
10.1517/17425247.2011.547469
P407
P577
2011-01-06T00:00:00Z